Page URL:

'Outstanding' results in as-yet-unpublished arthritis stem cell trials

16 July 2012
Appeared in BioNews 665

Two UK newspapers have hailed a potential treatment for osteoarthritis using a patient's own stem cells, although results from early studies in animals and patients are yet to be published.

The experimental technique was developed by Australian biotech company Regeneus and uses stem cells from the patient's fat tissue which are injected into affected joints. According to the Daily Express the technology has been 'startlingly successful in the treatment of osteoarthritis in pets'. Were it to be as successful in patients, the newspaper continues, it would delay 'the need for joint replacement by 10 or 20 years' and could stop disease progression entirely if diagnosed early.

However, these animal studies do not appear to have been published in a peer-reviewed publication. Results from an early clinical trial, which apparently took place last year at the Royal North Shore Hospital in Sydney, 'are not are not due to be published until 2013', according to the Daily Mail.

Judith Brodie, chief executive of the charity Arthritis Care, cautiously welcomed the news: 'This new stem cell therapy, if the trials continue to show success, could be transformational. While the long-term effects are unknown, and there should be caution due to the early stage of development, Arthritis Care welcomes progress in treating this painful condition'.

In osteoarthritis the cartilage in people's joints degenerates, causing pain and reduced movement. There is currently no cure and in severe cases joint replacement surgery is required. Regeneus' therapy aims to replace lost or damaged stem cells in the joint, reducing inflammation and promoting cartilage regrowth.

The company also reports success of its technology in a mouse model of rheumatoid arthritis. Professor Maree Smith, from the University of Queensland, who was involved in the as-yet-unpublished work said: 'A key finding was that secretions from a mixture of mesenchymal stem cells and adipocytes [fat cells] are more therapeutically powerful than secretions from mesenchymal stem cells alone'.

However, Brodie pointed out the complexity of arthritic disease and the need for more research, saying: 'At the moment stem cells are not the 'magic bullet' and they don't solve the underlying problem of osteoarthritis, which still needs to be addressed'.

In the UK as many as ten million people may have some form of arthritis. The Daily Mail reports that the NHS currently spends around £1 billion on knee replacement surgeries.

Arthritis stem cell jab 'could ease pain for million
Mail Online |  10 July 2012
Body fat injection ends years of pain for arthritis sufferers
Express |  10 July 2012
Regeneus validates therapeutic benefits of stem cell secretions platform
Regeneus (press release) |  11 July 2012
6 January 2014 - by Dr James Heather 
The largest genetic study of rheumatoid arthritis to date has found an additional 42 disease-associated locations in the genome...
18 March 2013 - by Sarah Pritchard 
Stem cells taken from patients' own fat tissue could potentially be used to deliver treatments direct to brain tumours, say scientists after early laboratory tests...
18 March 2013 - by Reuben Harwood 
An experimental gene therapy that protects cartilage from wear and deterioration has been shown to slow the development of osteoarthritis in mice....
7 January 2013 - by Dr Greg Ball 
Immune cells that can recognise and kill cancer cells have been grown from induced pluripotent stem cells (iPSCs)...
6 June 2012 - by Maren Urner 
A stem cell technique to treat the common bone disease osteonecrosis is being pioneered at Southampton General Hospital in the UK...
12 March 2012 - by Dr Rebecca Robey 
Stem cell therapy may remove the need for organ transplant recipients to have lifelong drug treatment to combat the risk of rejection, which would dramatically improve patients' quality of life...
5 March 2012 - by Cathy Holding 
A major clinical trial to investigate a stem cell treatment for chronic ischemic heart disease (IHD) – a leading cause of death around the world – has begun in the US...
21 November 2011 - by Dr Zara Mahmoud 
The world's first stem cell therapy to repair torn cartilage in the knee has been brought one step closer. Professor Anthony Hollander, co-founder of University of Bristol spin-out Azellon Cell Therapeutics, has just received funding of £65,000 to carry out clinical trials on the use of a patient's own stem cells for knee repair...
14 April 2009 - by Rose Palmer 
A team of scientists at Keele University are working on an injectable stem cell shot that will repair joints and bones anywhere in the body. The research was presented at the UK National Stem Cell Network annual conference in Oxford. Professor Alicia El Haj and Professor John...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.